Different pattern of the second outbreak of COVID-19 in Marseille, France

被引:10
作者
Gautret, Philippe [1 ,2 ]
Colson, Philippe [1 ,3 ]
Lagier, Jean Christophe [1 ,3 ]
Camoin-Jau, Laurence [1 ,3 ,4 ]
Giraud-Gatineau, Audrey [1 ,3 ]
Boudjema, Sophia [1 ,3 ]
Finance, Julie [1 ,3 ,5 ]
Chaudet, Herve [1 ,2 ]
Raoult, Didier [1 ,3 ]
机构
[1] IHU Mediterranee Infect, 19-21 Blvd Jean Moulin, F-13005 Marseille, France
[2] Aix Marseille Univ, Inst Rech Dev IRD, AP HM, Serv Sante Armees SSA,Vecteurs Infect Trop & Medi, Marseille, France
[3] Aix Marseille Univ, Inst Rech Dev IRD, AP HM, Microbes Evolut Phylogeny & Infect MEPHI, 27 Blvd Jean Moulin, F-13005 Marseille, France
[4] Hop La Timone, AP HM, Lab Hematol, Blvd Jean Moulin, F-13005 Marseille, France
[5] Aix Marseille Univ, Explorat Fonct Resp, Assistance Publ Marseille, Marseille, France
关键词
COVID-19; Seasonality; Severity markers; Lethality;
D O I
10.1016/j.ijid.2020.10.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To describe the characteristics of COVID-19 patients seen in March-April and June-August 2020 in Marseille, France with the aim to investigate possible changes in the disease between these two time periods. Methods: Demographics, hospitalization rate, transfer to intensive care unit (ICU), lethality, clinical and biological parameters were investigated. Results: Compared to those seen in March-April, COVID-19 patients seen in June-August were significantly younger (39.2 vs. 45.3 years), more likely to be male (52.9% vs. 45.6%), and less likely to be hospitalized (10.7 vs. 18.0%), to be transferred to ICU (0.9% vs. 1.8%) and to die (0.1% vs. 1.1%). Their mean fibrinogen and D-dimer blood levels were lower (1.0 vs. 1.5 g/L and 0.6 vs. 1.1 mg/mL, respectively). By contrast, their viral load was higher (cycle threshold s16 = 5.1% vs. 3.7%). Conclusions: Patients in the two periods did not present marked age and sex differences, but markers of severity were undoubtedly less prevalent in the summer period, associating with a 10 times decrease in the lethality rate. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:17 / 19
页数:3
相关论文
共 6 条
[1]  
[Anonymous], EuroMOMO Bulletin
[2]  
[Anonymous], 2020, WHO DIRECTOR GEN OPE
[3]   Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis [J].
Lagier, Jean-Christophe ;
Million, Matthieu ;
Gautret, Philippe ;
Colson, Philippe ;
Cortaredona, Sebastien ;
Giraud-Gatineau, Audrey ;
Honore, Stephane ;
Gaubert, Jean-Yves ;
Fournier, Pierre-Edouard ;
Tissot-Dupont, Herve ;
Chabriere, Eric ;
Stein, Andreas ;
Deharo, Jean-Claude ;
Fenollar, Florence ;
Rolain, Jean-Marc ;
Obadia, Yolande ;
Jacquier, Alexis ;
La Scola, Bernard ;
Brouqui, Philippe ;
Drancourt, Michel ;
Parola, Philippe ;
Raoult, Didier .
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 36
[4]  
Nicolle C., 1939, DESTIN MALADIES INFE, V3e
[5]   Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses [J].
Su, Shuo ;
Wong, Gary ;
Shi, Weifeng ;
Liu, Jun ;
Lai, Alexander C. K. ;
Zhou, Jiyong ;
Liu, Wenjun ;
Bi, Yuhai ;
Gao, George F. .
TRENDS IN MICROBIOLOGY, 2016, 24 (06) :490-502
[6]   MERS, SARS and other coronaviruses as causes of pneumonia [J].
Yin, Yudong ;
Wunderink, Richard G. .
RESPIROLOGY, 2018, 23 (02) :130-137